drugset / Trial / NCT05643729
Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupTriple-blindTreatment
Summary
A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of Zofin for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).
Timeline
- Start
- 2023-11-15
- Primary completion
- 2024-05-30
- Completion
- 2024-08-31
Outcome
Outcome not reported
Stopped: “Study is on hold”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zofin | Other / unclassified | 1 ml | Intravenous |